v3 Template
E

Emergent BioSolutions Inc.

Life Sciences / Public Health Gaithersburg, Md. and Basel, Switzerland ~135 employees
Founded
--
Employees (Est.)
~135
9 leaders known
Total Funding
$250.0M
Funding Rounds
1
Last Funding
2024-09-04

About Emergent BioSolutions Inc.

Emergent BioSolutions is a global specialty life sciences company focused on protecting and saving lives by delivering protective and life-saving solutions to communities worldwide. Their mission is to lead a new way forward for public health, addressing critical health threats and preparedness.

Products & Services

Commercial Products:Products addressing endemic public health threats such as the opioid epidemic.
Medical Countermeasures (MCM):Development, manufacturing, and supply of medical countermeasures for national security and public health preparedness.
Strategic Partnerships:Support for biopharma innovators, governments, and NGOs with development and manufacturing needs using specialized in-house capabilities.
NARCAN® Nasal Spray:A product highlighted in campaigns to address opioid emergencies.
TEMBEXA® (brincidofovir):An oral suspension antiviral for smallpox.
ACAM2000® (Smallpox and Mpox Vaccine, Live):A vaccine for smallpox and mpox supplied to the U.S. government.
BAT® (Botulism Antitoxin Heptavalent)
ACAM2000® (Smallpox and Mpox Vaccine)

Specialties

Medical Countermeasures Opioid Crisis Solutions Public Health Preparedness Biopharma Manufacturing Partnerships Medical countermeasures development and manufacturing Biothreat preparedness Opioid epidemic solutions Strategic manufacturing partnerships

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 250000000
MR: -
FA: $250 million
FAN: 250000000
D: 2024-09-04
FD: 2024-09-04
1 investors
Debt Latest
2024-09-04
$250.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

J

Joseph Papa

President and Chief Executive Officer

R

Richard S. Lindahl

Executive Vice President, Chief Financial Officer

C

Coleen Glessner

Executive Vice President Quality and Ethics and Compliance

S

Simon Lowry

Chief Medical Officer, Head of Research and Development

P

Paul Williams

Senior Vice President, Products Business

J

Jessica Perl

Senior Vice President, General Counsel and Corporate Secretary

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Emergent BioSolutions Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Life Sciences / Public Health
Company Size
~135 employees (est.)
Locations
Gaithersburg, Md. and Basel, Switzerland

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro